CANY
TMO icon

Caxton Associates (New York)’s Thermo Fisher Scientific TMO Stock Holding History

Caxton Associates (New York)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-40,000
Closed -$5.37M – 200
2015
Q1 		$5.37M Buy
+40,000
New +$5.16M 0.22% 76

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s TMO Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 4,914 shares — an estimated $2.61M sold.

Caxton Associates (New York) first reported a position in TMO in Q4 2013 and held it in 18 quarters. The position peaked at $5.64M in Q4 2016. 2,528 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,914 Thermo Fisher Scientific shares in Q1 2024, an estimated $2.61M.
  • Caxton Associates (New York) first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 18 quarters.
  • Caxton Associates (New York)'s Thermo Fisher Scientific position peaked at $5.64M in Q4 2016.
  • 2,528 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.